Brief: Myriad Genetics And Gabbi To Work Together To Increase Access To Hereditary Cancer Risk Assessment Tools
27/02/2025 22:17
Feb 27 (Reuters) - Myriad Genetics Inc MYGN.O: MYRIAD GENETICS AND GABBI TO WORK TOGETHER TO INCREASE ACCESS TO HEREDITARY CANCER RISK ASSESSMENT TOOLS Source text: ID:nGNX6K5Vrj Further company coverage: MYGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple